# Foresite Capital Management V, LLC: Form 13F holdings

An institutional investment manager in WEST HOLLYWOOD, CA. SEC CIK 1792206.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $362.2m
- Positions: 9 (9 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1792206/000110465926097121/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [ALUMIS INC. (ALMS)](/companies/alms.md) | COM | $165.9m | 45.8% | 5,896,995 |  | Unchanged |
| [CG Oncology, Inc. (CGON)](/companies/cgon.md) | COM | $76.7m | 21.2% | 1,079,050 |  | Added +75,000 |
| [Disc Medicine, Inc. (IRON)](/companies/iron.md) | COM | $27.4m | 7.6% | 374,069 |  | Unchanged |
| [Hims & Hers Health, Inc. (HIMS)](/companies/hims.md) | COM CL A | $25.6m | 7.1% | 738,151 |  | Unchanged |
| Pharvaris N.V. | COM | $23.0m | 6.3% | 664,142 |  | Added +470,017 |
| [Eikon Therapeutics, Inc. (EIKN)](/companies/eikn.md) | COM | $17.2m | 4.8% | 1,318,983 |  | Unchanged |
| [Odyssey Therapeutics, Inc. (ODTX)](/companies/odtx.md) | COM | $13.3m | 3.7% | 713,105 |  | New +713,105 |
| [Lyell Immunopharma, Inc. (LYEL)](/companies/lyel.md) | COM | $6.7m | 1.8% | 476,386 |  | Reduced −692 |
| [Nurix Therapeutics, Inc. (NRIX)](/companies/nrix.md) | COM | $6.4m | 1.8% | 265,000 |  | Unchanged |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [Maze Therapeutics, Inc. (MAZE)](/companies/maze.md) | COM | $0 | 0.0% | 0 |  | Sold out −25,905 |

Source: SEC EDGAR, Form 13F-HR, accession 0001104659-26-097121. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.